Literature DB >> 29517973

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.

Willy A Flegel1, Qing Chen2, Lilian Castilho3, Margaret A Keller4, Ellen B Klapper5, William J Lane6, France Pirenne7, Gary Stack8, Maryse St-Louis9, Christopher A Tormey8, Dan A Waxman10, Christof Weinstock11, Silvano Wendel12, Gregory A Denomme13.   

Abstract

Mesh：

Year:  2018        PMID： 29517973      PMCID： PMC6125235          DOI： 10.2450/2018.0260-17

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  68 in total

1.  Molecular basis of the globoside-deficient P(k) blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene.

Authors:  Asa Hellberg; Joyce Poole; Martin L Olsson
Journal:  J Biol Chem       Date:  2002-05-21       Impact factor: 5.157

Review 2.  Considerations of red blood cell molecular testing in transfusion medicine.

Authors:  Annika M Svensson; Meghan Delaney
Journal:  Expert Rev Mol Diagn       Date:  2015-09-14       Impact factor: 5.225

3.  The importance of antibody screens after transfusions.

Authors:  Steven R Sloan
Journal:  Transfusion       Date:  2016-11       Impact factor: 3.157

4.  Genotyping patients' and donors' blood groups for efficient blood therapy.

Authors:  Silvia Manfroi; Pasqualepaolo Pagliaro
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

5.  Homozygous Southeast Asian ovalocytosis is a severe dyserythropoietic anemia associated with distal renal tubular acidosis.

Authors:  Véronique Picard; Alexis Proust; Marion Eveillard; Joanna F Flatt; Marie-Laure Couec; Gaêlle Caillaux; Madeleine Fénéant-Thibault; Arie Finkelstein; Martine Raphaël; Jean Delaunay; Lesley J Bruce; Serge Pissard; Caroline Thomas
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

6.  A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient.

Authors:  Markus Anliker; Inge von Zabern; Britta Höchsmann; Henriette Kyrieleis; Christian Dohna-Schwake; Willy A Flegel; Hubert Schrezenmeier; Christof Weinstock
Journal:  Transfusion       Date:  2014-01-03       Impact factor: 3.157

7.  Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab.

Authors:  Wendy L Disbro
Journal:  Immunohematology       Date:  2017-09

8.  Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; R Sue Shirey; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2013-05-21       Impact factor: 3.157

Review 9.  McLeod syndrome: a neurohaematological disorder.

Authors:  H H Jung; A Danek; B M Frey
Journal:  Vox Sang       Date:  2007-08       Impact factor: 2.144

10.  Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study.

Authors:  Elizabeth S Allen; Kshitij Srivastava; Matthew M Hsieh; Courtney D Fitzhugh; Harvey G Klein; John F Tisdale; Willy A Flegel
Journal:  Lancet Haematol       Date:  2017-11       Impact factor: 18.959
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.